SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: majander who wrote (8005)5/11/1998 10:11:00 PM
From: scope  Respond to of 23519
 
Sure!!!!!
If Viagra doesn't do it,NEXMED will.VVUS will be history within nine to twelve months. Alprox-TD is much effective and not painful. Is coming to town soon. Check out NEXM.
Don't even bother to ask them for the new plant approval. WILL BE NO NEED FOR ONE.



To: majander who wrote (8005)5/11/1998 11:53:00 PM
From: Mkilloran  Read Replies (1) | Respond to of 23519
 
Majander...I think you are correct...Vivus wil have a slice of a bigger pie...the bottom is forming and a short squeeze is just around the corner....

Now what will be the trigger ...FDA approval of new plant, growing overseas sales, expanded sales force, more countries approved, Viagra customers moving to MUSE , recovery and expansion of script numbers.,.......ALL OF THE ABOVE ....annual stockholders meeting later this month should be interesting.........
Wall Street eps revisions and upgrades on the way soon................
.